Trial of Ixazomib for Kaposi Sarcoma
Trial of Ixazomib for Kaposi Sarcoma
Recruiting · NCT04305691 · Registry updated 2026-02-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trial of Ixazomib for Kaposi Sarcoma | DNA Virus Infections, Herpesviridae infectious disease, Infections, Kaposi's sarcoma, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma, vascular cancer, viral infectious disease | Recruiting | Phase 2 | 2026-02-27 | NCT04305691 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AIDS Malignancy Consortium | 11 |
| National Cancer Institute (NCI) | 3015 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Abramson Cancer Center at Pennsylvania Hospital | Philadelphia | United States | 3 |
| Mount Sinai Hospital | New York | United States | 225 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Baltimore | United States | 24 |
| Thomas Street Clinic | Houston | United States | 1 |
| UC San Diego | San Diego | United States | 5 |
| University of Illinois Cancer Center | Chicago | United States | 34 |
| University of Miami Miller School of Medicine | Miami | United States | 28 |
| Virginia Mason Medical Center | Seattle | United States | 111 |
| Washington University | St Louis | United States | 182 |
| Zuckerberg San Francisco General Hospital | San Francisco | United States | 42 |